NDC 51672-1402-08 - Calcipotriene and Betamethasone Dipropionate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-1402
- Requested NDC
- 51672-1402-08
- Package NDCs from labels
- 51672-1402-4, 51672-1402-8, 51672-1402-08
- Manufacturer
- Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc.
- Effective date
- 2025-07-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| MINERAL OIL - Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc. | Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc. | 2025-07-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-1402-4 | Calcipotriene and Betamethasone Dipropionate | 60 g in 1 BOTTLE | SUSPENSION | 60 | 2 | |
| 51672-1402-4 | Calcipotriene and Betamethasone Dipropionate | 1 in 1 CARTON | SUSPENSION | 1 | 2 | |
| 51672-1402-8 | Calcipotriene and Betamethasone Dipropionate | 60 g in 1 BOTTLE | SUSPENSION | 60 | 2 | |
| 51672-1402-8 | Calcipotriene and Betamethasone Dipropionate | 2 in 1 CARTON | SUSPENSION | 2 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-1402 | CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE SUSPENSION [TARO PHARMACEUTICALS U.S.A., INC.] | 1 | Current NDC, Legacy NDC, 4 package rows | 20200904_1d0ab2e6-1ab1-4d3e-ad55-7fa26446f191.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | A-S Medication Solutions | 5137f94e-6818-440b-a33e-228aa27de61d | 2024-07-30 | Adverse reactions | 826Y60901U |
| Clotrimazole and Betamethasone Dipropionate | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | NORTHSTAR RX LLC | 8d03b9ba-f7a8-4fbf-9be1-83d815c2be45 | 2024-06-20 | Warnings, Adverse reactions | 826Y60901U |
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | NuCare Pharmaceuticals,Inc. | 84b37e6a-779e-5d43-e053-2a91aa0a16b7 | 2024-06-14 | Warnings, Adverse reactions | 826Y60901U |
| BETAMETHASONE DIPROPIONATE | BETAMETHASONE DIPROPIONATE | Aurobindo Pharma Limited | e0e0baea-1744-4708-bda7-4ab7783a3fb4 | 2024-06-05 | Warnings, Adverse reactions | 826Y60901U |
| Clotrimazole and Betamethasone Dipropionate | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | NuCare Pharmaceuticals,Inc. | 5cc511e4-3e7d-70d6-e053-2a91aa0a8044 | 2024-06-04 | Warnings, Adverse reactions | 826Y60901U |
| calcipotriene | CALCIPOTRIENE | Mayne Pharma | 26756ac7-a80c-49db-97bb-351f76ad8a71 | 2024-05-09 | Warnings, Adverse reactions | 143NQ3779B |
| SORILUX | CALCIPOTRIENE | Mayne Pharma | 51f208d0-7b3f-44cc-8bed-92fa3d2e7bbe | 2024-05-09 | Warnings, Adverse reactions | 143NQ3779B |
| Calcipotriene and Betamethasone Dipropionate | CALCIPOTRIENE, BETAMETHASONE DIPROPIONATE | Padagis Israel Pharmaceuticals Ltd | ba55ff2b-9cfe-40dc-9dac-718cf141c171 | 2024-04-30 | Warnings, Adverse reactions | 143NQ3779B 826Y60901U |
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | Actavis Pharma, Inc. | ab332791-461b-4396-9b46-7f00bc04c087 | 2024-04-08 | Adverse reactions | 826Y60901U |
| FLEET | MINERAL OIL | C.B. Fleet Company, Inc. | e0b7acab-add4-4daf-b1df-bb7cf5ca8e19 | 2024-04-01 | Warnings | T5L8T28FGP |
| BETAMETHASONE DIPROPIONATE | BETAMETHASONE DIPROPIONATE | Padagis Israel Pharmaceuticals Ltd | 0e56e8bc-b79e-43c6-945e-c333a599bfc8 | 2024-03-31 | Adverse reactions | 826Y60901U |
| PREPARATION H | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Haleon US Holdings LLC | 507c08ab-a98b-33fe-e2ac-eb9b9a810d5a | 2024-02-29 | Warnings | T5L8T28FGP |
| Calcipotriene and Betamethasone Dipropionate | CALCIPOTRIENE, BETAMETHASONE DIPROPIONATE | Bryant Ranch Prepack | d223e857-590e-48b9-b33e-1275537a508e | 2024-02-08 | Warnings, Adverse reactions | 143NQ3779B 826Y60901U |
| ER Hemorrhoid | PHENYLEPHRINE HCL | EVER READY FIRST AID | 3cf29fc0-af4d-4610-a426-894601d5e078 | 2024-02-02 | Warnings | T5L8T28FGP |
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | Bryant Ranch Prepack | 79256f36-adff-4628-abc5-cb25bdfdc19d | 2024-01-11 | Warnings, Adverse reactions | 826Y60901U |
| Quflora Pediatric | VITAMIN A ACETATE, ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL, DL-, THIAMINE HYDROCHLORIDE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE, LEVOMEFOLIC ACID, FOLIC ACID, CYANOCOBALAMIN, MAGNESIUM OXIDE, CUPRIC SULFATE, AND SODIUM FLUORIDE | CarWin Pharmaceutical Associates, LLC | b8e08798-d8bb-4616-996b-a2c07a5d730a | 2024-01-10 | Warnings, Adverse reactions | 7QWA1RIO01 |
| A11 ENVIRO-PROTECT | ALLIUM SATIVUM, ALTERNARIA ALTERNATA, ASCORBICUM ACIDUM, ASPERGILLUS NIGER, AUREOBASIDIUM PULLULANS, BERBERIS VULGARIS, CADMIUM METALLICUM, CARBONEUM OXYGENISATUM, CHELIDONIUM MAJUS, CHLORINUM, CLADOSPORIUM PHAEROSPERMUM, COCHLIOBOLUS SATIVUS, COCHLIOBOLUS SPICIFER, GIBBERELLA FUJIKUROI, HOUSE DUST, LEAD, LYCOPODIUM CLAVATUM, MALUS SYLVESTRIS, MUCOR PLUMBEUS, NIACIN, PENICILLIUM NOTATUM, PETROLATUM, PHENOL, QUERCUS ROBUR, RHIZOPUS STOLONIFER, SOLIDAGO VIRGAUREA, TABACUM, VITAMIN A, VITAMIN E | Apex Energetics Inc. | bf8f4f21-832c-5258-e053-2995a90a6831 | 2024-01-08 | Warnings | T5L8T28FGP |
| Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCI | Cardinal Health 110 dba LEADER | a5a261c2-1f36-c895-e053-2a95a90ab22b | 2024-01-02 | Warnings | T5L8T28FGP |
| Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Proficient Rx LP | 105095e3-843e-4153-adc9-266dd14929a2 | 2024-01-01 | Warnings | T5L8T28FGP |
| Mineral Oil Heavy | MINERAL OIL | Pharma Nobis, LLC | e42f6c6d-c4de-02c6-e053-2995a90a3ace | 2023-12-22 | Warnings | T5L8T28FGP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.